248 related articles for article (PubMed ID: 19407824)
1. Blockade of angiotensin II type-1 receptor increases salt sensitivity in Sprague-Dawley rats.
Endo S; Mori T; Yoneki Y; Nakamichi T; Hosoya T; Ogawa S; Tokudome G; Hosoya T; Miyata T; Ito S
Hypertens Res; 2009 Jun; 32(6):513-9. PubMed ID: 19407824
[TBL] [Abstract][Full Text] [Related]
2. Changing dietary sodium alters the chronic cardiovascular effects of losartan in rats.
Collister JP; Nahey DB
J Renin Angiotensin Aldosterone Syst; 2008 Mar; 9(1):10-6. PubMed ID: 18404603
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis.
Fukuda M; Yamanaka T; Mizuno M; Motokawa M; Shirasawa Y; Miyagi S; Nishio T; Yoshida A; Kimura G
J Hypertens; 2008 Mar; 26(3):583-8. PubMed ID: 18300871
[TBL] [Abstract][Full Text] [Related]
4. Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats.
Husková Z; Kramer HJ; Vanourková Z; Cervenka L
J Hypertens; 2006 Mar; 24(3):517-27. PubMed ID: 16467655
[TBL] [Abstract][Full Text] [Related]
5. Oxidant stress and blood pressure responses to angiotensin II administration in rats fed varying salt diets.
Pech V; Sikka SC; Sindhu RK; Vaziri ND; Majid DS
Am J Hypertens; 2006 May; 19(5):534-40. PubMed ID: 16647629
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats.
Yoshida K; Kobayashi N; Ohno T; Fukushima H; Matsuoka H
J Hypertens; 2007 Aug; 25(8):1633-42. PubMed ID: 17620960
[TBL] [Abstract][Full Text] [Related]
7. Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method.
Araki S; Hirooka Y; Kishi T; Yasukawa K; Utsumi H; Sunagawa K
Hypertens Res; 2009 Dec; 32(12):1091-6. PubMed ID: 19763130
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
Nishio M; Sakata Y; Mano T; Yoshida J; Ohtani T; Takeda Y; Miwa T; Masuyama T; Yamamoto K; Hori M
J Hypertens; 2007 Feb; 25(2):455-61. PubMed ID: 17211254
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
Whaley-Connell A; Govindarajan G; Habibi J; Hayden MR; Cooper SA; Wei Y; Ma L; Qazi M; Link D; Karuparthi PR; Stump C; Ferrario C; Sowers JR
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E355-63. PubMed ID: 17440033
[TBL] [Abstract][Full Text] [Related]
10. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
[TBL] [Abstract][Full Text] [Related]
11. Remodeling and angiotensin II responses of the uterine arcuate arteries of pregnant rats are altered by low- and high-sodium intake.
St-Louis J; Sicotte B; Beauséjour A; Brochu M
Reproduction; 2006 Feb; 131(2):331-9. PubMed ID: 16452726
[TBL] [Abstract][Full Text] [Related]
12. Influence of dietary sodium on the blood pressure and renal sympathetic nerve activity responses to intracerebroventricular angiotensin II and angiotensin III in anaesthetized rats.
Houghton BL; Huang C; Johns EJ
Exp Physiol; 2010 Feb; 95(2):282-95. PubMed ID: 19880539
[TBL] [Abstract][Full Text] [Related]
13. Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats.
Dejima T; Tamura K; Wakui H; Maeda A; Ohsawa M; Kanaoka T; Haku S; Kengo A; Masuda S; Shigenaga A; Azuma K; Matsuda M; Yabana M; Hirose T; Uchino K; Kimura K; Nagashima Y; Umemura S
J Hypertens; 2011 Oct; 29(10):1919-29. PubMed ID: 21844822
[TBL] [Abstract][Full Text] [Related]
14. Low sodium intake induces an increase in renal monoamine oxidase activity in the rat. Involvement of an angiotensin II dependent mechanism.
De Luca Sarobe V; Nowicki S; Carranza A; Levin G; Barontini M; Arrizurieta E; Ibarra FR
Acta Physiol Scand; 2005 Oct; 185(2):161-7. PubMed ID: 16168010
[TBL] [Abstract][Full Text] [Related]
15. Effects of dietary salt on intrarenal angiotensin system, NAD(P)H oxidase, COX-2, MCP-1 and PAI-1 expressions and NF-kappaB activity in salt-sensitive and -resistant rat kidneys.
Chandramohan G; Bai Y; Norris K; Rodriguez-Iturbe B; Vaziri ND
Am J Nephrol; 2008; 28(1):158-67. PubMed ID: 17951998
[TBL] [Abstract][Full Text] [Related]
16. Sex-differences in circadian blood pressure variations in response to chronic angiotensin II infusion in rats.
Sampson AK; Widdop RE; Denton KM
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):391-5. PubMed ID: 18307727
[TBL] [Abstract][Full Text] [Related]
17. High salt intake enhances blood pressure increase during development of hypertension via oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats.
Koga Y; Hirooka Y; Araki S; Nozoe M; Kishi T; Sunagawa K
Hypertens Res; 2008 Nov; 31(11):2075-83. PubMed ID: 19098380
[TBL] [Abstract][Full Text] [Related]
18. Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis.
Kim HJ; Sato T; Rodríguez-Iturbe B; Vaziri ND
J Pharmacol Exp Ther; 2011 Jun; 337(3):583-90. PubMed ID: 21357516
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor blocker attenuates PDGF-induced mesangial cell migration in a receptor-independent manner.
Ishizawa K; Izawa-Ishizawa Y; Dorjsuren N; Miki E; Kihira Y; Ikeda Y; Hamano S; Kawazoe K; Minakuchi K; Tomita S; Tsuchiya K; Tamaki T
Nephrol Dial Transplant; 2010 Feb; 25(2):364-72. PubMed ID: 19812233
[TBL] [Abstract][Full Text] [Related]
20. Olmesartan induces renoprotective effects by stimulating angiotensin type 2 receptors and reducing oxidative stress in diabetic nephropathy.
Jo F; Morimoto S; Nakahigashi M; Kusabe M; Someya K; Morita T; Jo H; Imada T; Kosaki A; Toyoda N; Nishikawa M; Iwasaka T
Kidney Blood Press Res; 2011; 34(6):418-23. PubMed ID: 21709422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
